Brief: BioInvent, Transgene Report Positive Phase 1a Data On Oncolytic Virus Bt-001 In Solid Tumors
25/05/2023 06:38
May 25 (Reuters) - BioInvent International AB BINV.ST :
* BIOINVENT AND TRANSGENE REPORT POSITIVE PHASE 1A DATA ON
ONCOLYTIC VIRUS BT-001 IN SOLID TUMORS
* INDEPENDENT SAFETY REVIEW COMMITTEE HAS NOW APPROVED
INITIATION
OF COMBINATION PART OF TRIAL WITH PEMBROLIZUMAB
* FIRST PATIENT IN THIS COMBINATION COHORT IS EXPECTED TO BE
ENROLLED IN H2 2023
Source text for Eikon: ID:nMFNMqG2V
Further company coverage: BINV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))